GSK-ATN117183

Study Sponsor: GSK

Study Title

Efficacy and safety of alitretinoin in the treatment of severe chronic hand eczema refractory to topical therapy

Medicine or Vaccine (generic name)

alitretinoin

Sponsor Identification Number

ATN117183

Trial Registry Identification Number(#'s)

NCT00817063

Medical Condition

Eczema

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This study is available in CDISC format.

Date Added to this Site

October 2019